Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2020 | 5452 | 30.9 | 44% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CELLULAR IMMUNOLOGY | journal | 93364 | 7% | 5% | 361 |
2 | IMMUNOLOGY | WoSSC | 93006 | 62% | 1% | 3373 |
3 | EPICUTANEOUS IMMUNIZATION | authKW | 57251 | 0% | 68% | 15 |
4 | JOURNAL OF IMMUNOLOGY | journal | 50389 | 13% | 1% | 696 |
5 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 50327 | 4% | 5% | 198 |
6 | HUMAN DEV BIOL | address | 46039 | 0% | 34% | 24 |
7 | ARTIFICIAL BOUNDARY LIPID | authKW | 33593 | 0% | 100% | 6 |
8 | CONTRASUPPRESSION | authKW | 33593 | 0% | 100% | 6 |
9 | EKSPERIMENTALNAYA ONKOLOGIYA | journal | 31806 | 2% | 7% | 84 |
10 | ANTITUMOR RESISTANCE | authKW | 30480 | 0% | 78% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 93006 | 62% | 1% | 3373 |
2 | Oncology | 8467 | 22% | 0% | 1188 |
3 | Medicine, Research & Experimental | 2575 | 9% | 0% | 499 |
4 | Cell Biology | 1081 | 9% | 0% | 500 |
5 | Allergy | 840 | 2% | 0% | 111 |
6 | Transplantation | 636 | 3% | 0% | 144 |
7 | Pathology | 354 | 3% | 0% | 163 |
8 | Biology | 240 | 3% | 0% | 142 |
9 | CYTOLOGY & HISTOLOGY | 139 | 0% | 0% | 15 |
10 | Pharmacology & Pharmacy | 37 | 4% | 0% | 242 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HUMAN DEV BIOL | 46039 | 0% | 34% | 24 |
2 | ALLERGY CLIN IMMUNOL SECT | 16680 | 0% | 11% | 27 |
3 | RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL | 10604 | 0% | 10% | 19 |
4 | COMPREHENS K LAN CANC | 7464 | 0% | 67% | 2 |
5 | ESTUDIOS ONCOL | 5704 | 0% | 15% | 7 |
6 | ALLERGY CLIN IMMUNOL SECT333 CEDAR ST | 5599 | 0% | 100% | 1 |
7 | ANATTRAUMA GRP | 5599 | 0% | 100% | 1 |
8 | ARTIFICIAL CELL TECHNOL | 5599 | 0% | 100% | 1 |
9 | BIOL MEDAWAR BLDG | 5599 | 0% | 100% | 1 |
10 | C015 | 5599 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELLULAR IMMUNOLOGY | 93364 | 7% | 5% | 361 |
2 | JOURNAL OF IMMUNOLOGY | 50389 | 13% | 1% | 696 |
3 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 50327 | 4% | 5% | 198 |
4 | EKSPERIMENTALNAYA ONKOLOGIYA | 31806 | 2% | 7% | 84 |
5 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY | 27954 | 0% | 20% | 25 |
6 | JOURNAL OF EXPERIMENTAL MEDICINE | 27618 | 5% | 2% | 247 |
7 | IMMUNOLOGY | 25842 | 4% | 2% | 202 |
8 | EUROPEAN JOURNAL OF IMMUNOLOGY | 15631 | 4% | 1% | 193 |
9 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 11568 | 1% | 3% | 65 |
10 | IMMUNOBIOLOGY | 9802 | 1% | 2% | 75 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EPICUTANEOUS IMMUNIZATION | 57251 | 0% | 68% | 15 | Search EPICUTANEOUS+IMMUNIZATION | Search EPICUTANEOUS+IMMUNIZATION |
2 | ARTIFICIAL BOUNDARY LIPID | 33593 | 0% | 100% | 6 | Search ARTIFICIAL+BOUNDARY+LIPID | Search ARTIFICIAL+BOUNDARY+LIPID |
3 | CONTRASUPPRESSION | 33593 | 0% | 100% | 6 | Search CONTRASUPPRESSION | Search CONTRASUPPRESSION |
4 | ANTITUMOR RESISTANCE | 30480 | 0% | 78% | 7 | Search ANTITUMOR+RESISTANCE | Search ANTITUMOR+RESISTANCE |
5 | CONCOMITANT RESISTANCE | 20151 | 0% | 60% | 6 | Search CONCOMITANT+RESISTANCE | Search CONCOMITANT+RESISTANCE |
6 | TABM | 16797 | 0% | 100% | 3 | Search TABM | Search TABM |
7 | NOCARDIA OPACA | 15548 | 0% | 56% | 5 | Search NOCARDIA+OPACA | Search NOCARDIA+OPACA |
8 | 984 | 11198 | 0% | 100% | 2 | Search 984 | Search 984 |
9 | ANTIGEN SPECIFIC SUPPRESSOR T CELL FACTOR | 11198 | 0% | 100% | 2 | Search ANTIGEN+SPECIFIC+SUPPRESSOR+T+CELL+FACTOR | Search ANTIGEN+SPECIFIC+SUPPRESSOR+T+CELL+FACTOR |
10 | ANTITUMOR CYTOTOXIC LYMPHOCYTES | 11198 | 0% | 100% | 2 | Search ANTITUMOR+CYTOTOXIC+LYMPHOCYTES | Search ANTITUMOR+CYTOTOXIC+LYMPHOCYTES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BEN-EFRAIM, S , (2001) IMMUNOMODULATING ANTICANCER ALKYLATING DRUGS: TARGETS AND MECHANISMS OF ACTIVITY.CURRENT DRUG TARGETS. VOL. 2. ISSUE 2. P. 197 -212 | 65 | 76% | 19 |
2 | ASHERSON, GL , COLIZZI, V , ZEMBALA, M , (1986) AN OVERVIEW OF T-SUPPRESSOR CELL CIRCUITS.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 4. ISSUE . P. 37-68 | 70 | 85% | 145 |
3 | PARASKEVAS, F , (1984) PATHWAYS OF T-CELL SUPPRESSION.CRC CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 5. ISSUE 2. P. 95-148 | 101 | 83% | 9 |
4 | PTAK, W , NAZIMEK, K , ASKENASE, PW , BRYNIARSKI, K , (2015) FROM MYSTERIOUS SUPERNATANT ENTITY TO MIRNA-150 IN ANTIGEN-SPECIFIC EXOSOMES: A HISTORY OF HAPTEN-SPECIFIC T SUPPRESSOR FACTOR.ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. VOL. 63. ISSUE 5. P. 345 -356 | 33 | 75% | 0 |
5 | DORF, ME , BENACERRAF, B , (1984) SUPPRESSOR CELLS AND IMMUNOREGULATION.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 2. ISSUE . P. 127-158 | 58 | 81% | 387 |
6 | EHRKE, MJ , (2003) IMMUNOMODULATION IN CANCER THERAPEUTICS.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 3. ISSUE 8. P. 1105-1119 | 45 | 63% | 51 |
7 | OHARA, RM , (1995) ANTIGEN-SPECIFIC SUPPRESSOR FACTOR: MISSING PIECES IN THE PUZZLE.IMMUNOLOGIC RESEARCH. VOL. 14. ISSUE 4. P. 252-262 | 41 | 84% | 6 |
8 | WEBB, DR , KRAIG, E , DEVENS, BH , (1994) SUPPRESSOR CELLS AND IMMUNITY.MECHANISMS OF IMMUNE REGULATION. VOL. 58. ISSUE . P. 146-192 | 84 | 42% | 10 |
9 | EHRKE, MJ , MIHICH, E , BERD, D , MASTRANGELO, MJ , (1989) EFFECTS OF ANTICANCER DRUGS ON THE IMMUNE-SYSTEM IN HUMANS.SEMINARS IN ONCOLOGY. VOL. 16. ISSUE 3. P. 230-253 | 46 | 75% | 70 |
10 | ASKENASE, PW , BRYNIARSKI, K , PALIWAL, V , REDEGELD, F , KORMELINK, TG , KERFOOT, S , HUTCHINSON, AT , VAN LOVEREN, H , CAMPOS, R , ITAKURA, A , ET AL (2015) A SUBSET OF AID-DEPENDENT B-1A CELLS INITIATES HYPERSENSITIVITY AND PNEUMOCOCCAL PNEUMONIA RESISTANCE.B-1 CELL DEVELOPMENT AND FUNCTION. VOL. 1362. ISSUE . P. 200 -214 | 31 | 53% | 0 |
Classes with closest relation at Level 2 |